HT-1376 In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)

CAT#: ITS-1022-YF2847
Target Cell Organism: Human
Target Cell Name: HT-1376
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide HT-1376-based In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HT-1376
Target Cell Organism
Human
Target Cell Background
HT-1376 is an epithelial-like cell isolated from the urinary bladder of a White, 58-year-old, female with carcinoma. This cell line was deposited by S Rasheed and can be used for immuno-oncology research.
Related Diseases
Urinary Bladder Cancer
Research Area
Oncology
Assay Name
In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
Short Description
HT-1376-cell based In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
Assay Description
The 3H-thymidine incorporation assay is one such assay that can detect newly synthesized DNA in cells. Cultured cells are mixed with 3H-thymidine (radioactive) and kept for a desired incubation period. Newly replicated DNA strands can incorporate 3H-thymidine during mitosis. A scintillation counter is necessary to detect the output. Direct measurement of proliferating cells is the main advantage of this assay. However, use of harmful radioactive substances and need of special equipment are considered as main disadvantages.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.
Assay Subtype
Cell Proliferation Assay
Assay MOA
Cell-based Assays Based on DNA Synthesis
For Research Use Only | Not For Clinical Use
Online Inquiry